5.01 Statens Serum Institut ought to have competition
Statens Serum Institut has today a monopolistic role in relation to vaccines. It combines the functions of manufacturer, wholesaler, distributor and exporter.
Moreover, the Institute also acts as adviser to the government. This is a cause of serious distortion of competition in relation to the conditions applying to all other medicinal products and pharmaceutical companies. For example, the Danish child vaccination programme is based entirely on the Institute’s products. In many other countries, several manufacturers’ products are used, with beneficial competition as a consequence.
Lif is working for a solution to be found whereby the Institute’s supervisory and advisory functions are maintained, but its production of vaccines takes place on a competitive basis, with all manufacturers having equal conditions of competition.
Lif believes:
- that there no longer exist supply, health or economic arguments to justify the maintenance of the monopoly status that Statens Serum Institut has today, and
- that the Institute’s distribution monopoly should be abolished, so that all manufacturers can freely market and sell vaccines in Denmark.
|
Print
